Latest news
Recovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA - MedCity NewsMedCity News · Fri, 07 Aug 2026 22:12:34 GMTDispatch advances synthetic-antigen CAR T platform into first-in-human testing - AllSciAllSci · Fri, 07 Aug 2026 14:50:34 GMTHusband and wife oversee Carolina’s CAR-T therapy | UNC-Chapel Hill - The University of North Carolina at Chapel HillThe University of North Carolina at Chapel Hill · Wed, 29 Jul 2026 07:00:00 GMT